3rd Quarter - Report

BRACEWELL LLP for AQUESTIVE THERAPEUTICS

Period 3rd Quarter 2026 Filed Oct 14, 2026 Signed by Ellianna Gelardi

Official filing
Firm
BRACEWELL LLP
Client
AQUESTIVE THERAPEUTICS
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Consumer Issues/Safety/Products CSP

CPSC issues related to packaging

LobbyistCovered position, as disclosed
DYLAN PASIUK —
DANE PEDERSEN —
KYLE SPENCER —

Contacted: HOUSE OF REPRESENTATIVES; Consumer Product Safety Commission (CPSC); SENATE

Health Issues HCR

Issues related to therapeutics

LobbyistCovered position, as disclosed
DYLAN PASIUK —
DANE PEDERSEN —
KYLE SPENCER —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); White House Office; Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.